# First-into-human Study of NS-136 in Healthy Subjects

> **NCT06345703** · PHASE1 · RECRUITING · sponsor: **NeuShen Therapeutics** · enrollment: 76 (estimated)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** Placebo
- **DRUG:** NS-136 tablet

## Key facts

- **NCT ID:** NCT06345703
- **Lead sponsor:** NeuShen Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-30
- **Primary completion:** 2024-11
- **Final completion:** 2025-02
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06345703

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06345703, "First-into-human Study of NS-136 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06345703. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*